A Novel Human Growth Hormone XTEN Construct (VRS-317) for Once-a-Month Subcutaneous Administration in a Phase 1a Study of Growth Hormone–Deficient Adults

Jeffrey L. Cleland, Mark Kipnes(Diabetes & Glandular Disease Clinic), Benjamin Spink, Soha Motlagh, Nathan Geething, Joshua S. Silverman(NYU Langone Health), Yi Yao
Cited by 0


Related Papers